MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s10096-024-04790-2

Медицинская библиотека · European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2024

Validation of a new risk stratification system-based management for methicillin-resistant Staphylococcus aureus bacteraemia: analysis of a multicentre prospective study.

Kim Taeeun, Lee Sang-Rok, Park Seong Yeon, Moon Song Mi, Jung Jiwon, Kim Min Jae, Sung Heungsup, Kim Mi-Na, Kim Sung-Han, Choi Sang-Ho, Lee Sang-Oh, Kim Yang Soo, Song Eun Hee, Chong Yong Pil

СтатьяМногоцентровое исследованиеВалидационное исследованиеПеревод в очереди

Аннотация

PURPOSE: Distinguishing between complicated and uncomplicated Staphylococcus aureus bacteraemia (SAB) is therapeutically essential. However, this distinction has limitations in reflecting the heterogeneity of SAB and encouraging targeted diagnostics. Recently, a new risk stratification system for SAB metastatic infection, involving stepwise approaches to diagnosis and treatment, has been suggested. We assessed its applicability in methicillin-resistant SAB (MRSAB) patients.

METHODS

We retrospectively analysed data of a 3-year multicentre, prospective cohort of hospitalised patients with MRSAB. We classified the patients into three risk groups: low, indeterminate, and high, based on the new system and compared between-group management and outcomes.

RESULTS

Of 380 patients with MRSAB, 6.3% were classified as low-, 7.6% as indeterminate-, and 86.1% as high-risk for metastatic infection. No metastatic infection occurred in the low-, 6.9% in the indeterminate-, and 19.6% in the high-risk groups (P < 0.001). After an in-depth diagnostic work-up, patients were finally diagnosed as 'without metastatic infection (6.3%)', 'with metastatic infection (17.4%)', and 'uncertain for metastatic infection (76.3%)'. 30-day mortality increased as the severity of diagnosis shifted from 'without metastatic infection' to 'uncertain for metastatic infection' and 'with metastatic infection' (P = 0.09). In multivariable analysis, independent factors associated with metastatic complications were suspicion of endocarditis in transthoracic echocardiography, clinical signs of metastatic infection, Pitt bacteraemia score ≥ 4, and persistent bacteraemia.

CONCLUSIONS

The new risk stratification system shows promise in predicting metastatic complications and guiding work-up and management of MRSAB. However, reducing the number of cases labelled as 'high-risk' and 'uncertain for metastatic infection' remains an area for improvement.

Для цитирования: Kim Taeeun, Lee Sang-Rok, Park Seong Yeon, Moon Song Mi, Jung Jiwon, Kim Min Jae, Sung Heungsup, Kim Mi-Na, Kim Sung-Han, Choi Sang-Ho, Lee Sang-Oh, Kim Yang Soo, Song Eun Hee, Chong Yong Pil. Validation of a new risk stratification system-based management for methicillin-resistant Staphylococcus aureus bacteraemia: analysis of a multicentre prospective study.. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology. 2024. DOI: 10.1007/s10096-024-04790-2.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.